# Three-Arm Trial of Novel Treatment for Tinea Pedis

> **NCT03135912** · PHASE2 · COMPLETED · sponsor: **South End Skin Care** · enrollment: 90 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** Experimental Drug SESC 01
- **DRUG:** Placebo
- **DRUG:** Terbinafine Hydrochloride

## Key facts

- **NCT ID:** NCT03135912
- **Lead sponsor:** South End Skin Care
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2017-08-02
- **Final completion:** 2017-08-02
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03135912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03135912, "Three-Arm Trial of Novel Treatment for Tinea Pedis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03135912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*